Quantumscape Corp vs Veeva Systems — how do they compare? Quantumscape Corp trades at $4.58 (market cap $2.82B), while Veeva Systems trades at $296.5 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 16.4× Quantumscape Corp's market cap, and Veeva Systems is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Veeva Systems for 6 Days on average.
| QS | VEEV | |
|---|---|---|
Market Cap | $2.82B | $46.12B |
Volume | 21,878,246 | 921,537 |
Sector | Consumer Cyclical | Technology |
52-Week High | $18.44 | $299.10 |
52-Week Low | $4.52 | $151.43 |
Typical Hold Time | 37 Days | 6 Days |
Enterprise Value | $2.03B | $39.03B |
Signals from Pluang's Aura AI — not financial advice
QuantumScape (QS) trades at $4.58, up 1.33% with bearish technical signals and negative profitability metrics. The company remains pre-revenue with significant cash burn, though recent earnings beat expectations. Analyst consensus shows 72.7% hold ratings with a $10.35 price target, while insider selling and delayed commercialization timelines create headwinds.
QS faces substantial execution risk with commercialization not expected until 2029, but maintains automotive partnerships and pilot production progress. The stock trades near 52-week lows, offering potential upside to analyst targets if technology milestones are achieved, though high cash burn and competitive threats remain key concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →